Why the study?
Is the increased use of acetylsalicylic acid, P2Y12 inhibitors, statins, and percutaneous coronary intervention associated with a decreased incidence of ischemic stroke 30 days after an acute myocardial infarction?
Is the increased use of acetylsalicylic acid, P2Y12 inhibitors, statins, and percutaneous coronary intervention associated with a decreased incidence of ischemic stroke 30 days after an acute myocardial infarction?
The 30-day risk of ischemic stroke following an acute myocardial infarction declined between 1998 and 2008, correlating with the broader adoption of guideline-directed medical therapies and percutaneous coronary intervention.
No takes yet. Share an insight, caveat, or question.
Declining 30-day ischemic stroke risk after AMI was associated with greater antiplatelet, statin, and PCI use; leaves open causal effects in contemporary practice.
Kajermo et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: